Adaptive Biotechnologies Corp (ADPT)

Adaptive Biotechnologies Corp Azioni (ADPT) Dati Finanziari

Conto economico

Trimestrale

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	20.74% 45.78	37.92	48.93	37.65	55.20
Cost Of Revenue	1.40% 19.62	19.35	17.91	18.68	16.59
Gross Profit	40.89% 26.17	18.57	31.02	18.97	38.61
Operating Expenses	39.85% 97.24	69.53	78.83	76.16	77.80
Interest Income/Expense	17.52% 3.012	3.652	3.605	3.531	3.585
Benefits Costs and Expenses	30.60% 115.25	88.25	96.74	95.35	95.37
Costs And Expenses	31.48% 116.85	88.88	96.74	94.84	94.38
Operating Income/Loss	39.47% -71.07	-50.96	-47.82	-57.19	-39.19
Income/Loss From Continuing Operations Before Tax	38.03% -69.47	-50.33	-47.81	-57.70	-40.17
Income/Loss From Continuing Operations After Tax	38.03% -69.47	-50.33	-47.81	-57.70	-40.17
Net Income/Loss	38.03% -69.47	-50.33	-47.81	-57.70	-40.17
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	0.00% -0.026	-0.026	-0.001	-0.001	-0.041
Basic Average Shares	99.88% 0.1744	144.70	144.40	143.51	0.1816
Diluted Average Shares	99.88% 0.1744	144.70	144.40	143.51	0.1816
Basic Earnings Per Share	37.14% -0.48	-0.35	-0.33	-0.40	-0.28
Diluted Earnings Per Share	37.14% -0.48	-0.35	-0.33	-0.40	-0.28
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-